From Human to Veterinary Medicine: Expanding the Role of Microneedle Drug Delivery and Diagnostic Systems
Source abstract
Abstract
ABSTRACT Microneedles, typically 25–2000 µm in height, can be fabricated from metals, silicon, ceramics, or polymers, allowing precise customization for specific biomedical applications. While their potential is well established in human medicine, veterinary use remains limited. Nonetheless, recent studies indicate promising applications in pain management, vaccination, diagnostics, and dermatological therapy. This study presents findings that may support broader adoption of microneedles in veterinary medicine, highlighting key parallels with human research and evaluating their main advantages and limitations. By bridging the gap between human and veterinary drug delivery, microneedle technologies can reinforce translational medicine and advance the principles of the One Health framework, promoting integrated therapeutic innovation across species.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Microsystems Faculty of Electronics Photonics and Microsystems Wroclaw University of Science and Technology Wroclaw Poland
Funding
Politechnika Wrocławska
References (100+)
Show source-provided references
1. 10.3390/molecules2619590510.3390/molecules26195905 ↗
2. Routes of Drug Administration
3. 10.2174/221173850866620061321454810.2174/2211738508666200613214548 ↗
4. 10.2174/15672010978900048310.2174/156720109789000483 ↗
5. 10.1016/j.ijpharm.2021.12075610.1016/j.ijpharm.2021.120756 ↗
6. 10.1016/j.vas.2022.10023510.1016/j.vas.2022.100235 ↗
7. 10.1533/9780857097040.2.18510.1533/9780857097040.2.185 ↗
8. 10.1016/B978-0-12-801238-3.04255-010.1016/B978-0-12-801238-3.04255-0 ↗
9. 10.3390/scipharm9102002710.3390/scipharm91020027 ↗
10. 10.3762/bjnano.13.5510.3762/bjnano.13.55 ↗
11. 10.1007/s10544‐023‐00658‐y10.1007/s10544‐023‐00658‐y ↗
12. 10.1042/ETLS2020035310.1042/ETLS20200353 ↗
13. 10.1016/j.jconrel.2017.09.02510.1016/j.jconrel.2017.09.025 ↗
14. 10.1371/journal.pone.027216910.1371/journal.pone.0272169 ↗
15. 10.1038/s41598‐021‐86398‐610.1038/s41598‐021‐86398‐6 ↗
16. 10.1111/vde.1223610.1111/vde.12236 ↗
17. 10.1007/s40005‐021‐00512‐410.1007/s40005‐021‐00512‐4 ↗
18. 10.3390/pharmaceutics703009010.3390/pharmaceutics7030090 ↗
19. 10.3390/polym1316281510.3390/polym13162815 ↗
20. Mahato R. · 2017 · 331
21. 10.1002/smll.20220651010.1002/smll.202206510 ↗
22. 10.1016/j.mejo.2005.04.04410.1016/j.mejo.2005.04.044 ↗
23. 10.1021/acsabm.3c0075010.1021/acsabm.3c00750 ↗
24. 10.22159/ijap.2023v15i5.4842110.22159/ijap.2023v15i5.48421 ↗
25. 10.46419/vs.55.1.610.46419/vs.55.1.6 ↗
26. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
27. 10.1073/pnas.233131610010.1073/pnas.2331316100 ↗
28. 10.1016/B978-0-323-91811-4.00010-910.1016/B978-0-323-91811-4.00010-9 ↗
29. 10.1039/D2TB01648F10.1039/D2TB01648F ↗
30. Sensors | Free Full‐Text | Hollow Microneedles on a Paper Fabricated by Standard Photolithography for the Screening Test of Prediabetes https://www.mdpi.com/1424‐8220/22/11/4253.10.3390/s22114253 ↗
31. 10.1002/admt.20240028610.1002/admt.202400286 ↗
32. Simulation of Hollow Ormocomp Microneedles and Fabrication by Two Photon Photolithography. (Research Square (Research Square) 2024 https://doi.org/10.21203/rs.3.rs‐4468108/v1.
33. 10.35848/1347‐4065/ad3e0410.35848/1347‐4065/ad3e04 ↗
34. 10.1126/scitranslmed.aaw332910.1126/scitranslmed.aaw3329 ↗
35. 10.3390/s2412372910.3390/s24123729 ↗
36. 10.1021/acs.analchem.4c0568810.1021/acs.analchem.4c05688 ↗
37. 10.1063/5.020421610.1063/5.0204216 ↗
38. S.Sarker “Geometric Determinants of Cell Viability for 3D‐Printed Hollow Microneedle Array‐Mediated Delivery ” in2024 IEEE 37th International Conference on Micro Electro Mechanical Systems (MEMS)(IEEE 2024) 429–432 https://doi.org/10.1109/MEMS58180.2024.10439381.10.1109/MEMS58180.2024.10439381 ↗
39. 10.1016/j.jconrel.2022.05.04510.1016/j.jconrel.2022.05.045 ↗
40. 10.1111/j.2042‐7158.2011.01369.x10.1111/j.2042‐7158.2011.01369.x ↗
41. 10.1016/j.ijbiomac.2021.06.05910.1016/j.ijbiomac.2021.06.059 ↗
42. 10.1016/j.ejpb.2018.05.01710.1016/j.ejpb.2018.05.017 ↗
43. 10.1016/j.actbio.2020.07.02910.1016/j.actbio.2020.07.029 ↗
44. 10.1016/j.matdes.2021.10948510.1016/j.matdes.2021.109485 ↗
45. 10.1002/adhm.20180105410.1002/adhm.201801054 ↗
46. 10.1002/mabi.20220032310.1002/mabi.202200323 ↗
47. 10.1016/j.msec.2017.12.00610.1016/j.msec.2017.12.006 ↗
48. 10.1021/acs.biomac.8b0044110.1021/acs.biomac.8b00441 ↗
49. 10.1016/j.ejpb.2020.10.00210.1016/j.ejpb.2020.10.002 ↗
50. 10.3389/fbioe.2018.0005410.3389/fbioe.2018.00054 ↗
51. 10.3389/fphar.2021.71990510.3389/fphar.2021.719905 ↗
52. 10.3390/pharmaceutics1602020010.3390/pharmaceutics16020200 ↗
53. 10.1007/s13346‐018‐00593‐z10.1007/s13346‐018‐00593‐z ↗
54. 10.1126/sciadv.abe262010.1126/sciadv.abe2620 ↗
55. 10.1002/btm2.1035210.1002/btm2.10352 ↗
56. 10.1038/s41598‐025‐98984‐z10.1038/s41598‐025‐98984‐z ↗
57. 10.1016/j.jconrel.2013.05.02610.1016/j.jconrel.2013.05.026 ↗
58. 10.1002/adhm.20170032610.1002/adhm.201700326 ↗
59. 10.1016/j.ijpharm.2019.11899210.1016/j.ijpharm.2019.118992 ↗
60. 10.1002/adma.20090241810.1002/adma.200902418 ↗
61. 10.1016/j.mattod.2022.12.00710.1016/j.mattod.2022.12.007 ↗
62. 10.3390/polym1520405910.3390/polym15204059 ↗
63. 10.1007/s12257‐014‐0775‐010.1007/s12257‐014‐0775‐0 ↗
64. 10.1039/C8BM00005K10.1039/C8BM00005K ↗
65. 10.1016/j.biopha.2022.11371710.1016/j.biopha.2022.113717 ↗
66. 10.3390/pharmaceutics1502052610.3390/pharmaceutics15020526 ↗
67. 10.3390/ma1109162510.3390/ma11091625 ↗
68. 10.1021/acsami.3c0005810.1021/acsami.3c00058 ↗
69. 10.1016/j.jconrel.2006.10.01710.1016/j.jconrel.2006.10.017 ↗
70. 10.1124/jpet.119.25870710.1124/jpet.119.258707 ↗
71. 10.1016/S0168‐3659(04)00171‐310.1016/S0168‐3659(04)00171‐3 ↗
72. 10.1007/978-3-030-17971-7_10910.1007/978-3-030-17971-7_109 ↗
73. 10.1016/j.ijpharm.2015.01.03810.1016/j.ijpharm.2015.01.038 ↗
74. 10.1016/j.biomaterials.2020.12049110.1016/j.biomaterials.2020.120491 ↗
75. 10.1016/j.ijbiomac.2017.12.02710.1016/j.ijbiomac.2017.12.027 ↗
76. 10.1111/ics.1262710.1111/ics.12627 ↗
77. 10.1001/archdermatol.2012.28010.1001/archdermatol.2012.280 ↗
78. 10.1016/j.ejps.2008.06.01610.1016/j.ejps.2008.06.016 ↗
79. 10.1002/adtp.20200003310.1002/adtp.202000033 ↗
80. 10.1080/1061186X.2016.120058910.1080/1061186X.2016.1200589 ↗
81. 10.3390/mi1204043510.3390/mi12040435 ↗
82. 10.1016/j.jddst.2022.10349810.1016/j.jddst.2022.103498 ↗
83. 10.1016/j.ajps.2021.07.00210.1016/j.ajps.2021.07.002 ↗
84. 10.1002/asia.20220033310.1002/asia.202200333 ↗
85. 10.1115/1.404848110.1115/1.4048481 ↗
86. 10.1055/s-0040-170143510.1055/s-0040-1701435 ↗
87. 10.1016/j.drudis.2020.05.00610.1016/j.drudis.2020.05.006 ↗
88. 10.1016/j.jconrel.2019.10.02210.1016/j.jconrel.2019.10.022 ↗
89. Dissolving and Biodegradable Microneedle Technologies for Transdermal Sustained Delivery of Drug and Vaccine
90. 10.1016/j.jvacx.2023.10039810.1016/j.jvacx.2023.100398 ↗
91. 10.1007/s13346‐016‐0282‐210.1007/s13346‐016‐0282‐2 ↗
92. 10.1186/s41205-019-0039-x10.1186/s41205-019-0039-x ↗
93. 10.1007/s40268‐016‐0144‐x10.1007/s40268‐016‐0144‐x ↗
94. 10.1016/j.biomaterials.2017.02.04010.1016/j.biomaterials.2017.02.040 ↗
95. 10.1097/MEJ.000000000000021110.1097/MEJ.0000000000000211 ↗
96. 10.1016/j.jhsa.2012.07.00410.1016/j.jhsa.2012.07.004 ↗
97. 10.1111/j.1600‐0773.1985.tb01311.x10.1111/j.1600‐0773.1985.tb01311.x ↗
98. 10.1001/archderm.1971.0400021000500210.1001/archderm.1971.04000210005002 ↗
99. Transdermal Drug Delivery System in Veterinary Practice: An Overview
100. Transdermal Dosing Considerations for Veterinarians